Cochlear Limited · ASX:COH
Cochlear — Shareholder Meeting (October 2021)
25 slides from Cochlear's shareholder meeting presentation, Oct 19, 2021
Slide 1: Cochlear Limited 2021 Annual General Meeting
Hear now. And always Cochlear Limited 2021 Annual General Meeting 19 October 2021 © Cochlear Limited 2021 1
Slide 2: Acknowledgement of Country
Acknowledgement of Country Worimi, Welcome. On behalf of Cochlear, I would like to acknowledge the traditional custodians of the various lands in which we meet [virtually] today and pay respect to all Aboriginal Elders, past and present, and acknowledge today’s Aboriginal communities who are the cus
Slide 3: Board of directors
Board of directors Alison Deans Dig Howitt Yasmin Allen Andrew Denver Chair CEO & President Non‐executive Director Non‐executive Director Glen Boreham, AM Prof Bruce Robinson, AC Sir Michael Daniell, KNZM Christine McLoughlin, AM 3 Non‐executive Director Non‐executive Director Non‐executive Director
Slide 4: Cochlear's mission
Cochlear’s mission We help people hear and be heard. We empower people to connect with others and live a full life. We transform the way people understand and treat hearing loss. We innovate and bring to market a range of implantable hearing solutions that deliver a lifetime of hearing outcomes. 4
Slide 5: Long-term value creation: the impact we have on all our key stakeholders
Long‐term value creation: the impact we have on all our key stakeholders Key inputs to Customers & Innovation People & Financial & creating value communities capability capabilities environmental Retain Grow the Deliver consistent Our strategy market hearing revenue and leadership implant market ear
Slide 6: FY21 highlights
FY21 highlights A healthier & more productive society Transforming the way people understand and treat hearing loss by improving awareness and access. • WHO’s first ‘World Report on Hearing’ • Cost‐effectiveness studies • Cochlear implant v hearing aid trial • Partnership between the Cochlear Founda
Slide 7: FY21 highlights
FY21 highlights Thriving people An engaged, capable and high‐performing workforce that delivers on our strategy and supports the creation of sustained value. Targeting gender equality Growing employee engagement Gender diversity targets Where we are now Employee Board members 30% 30% 40% 38% engagem
Slide 8: FY21 highlights
FY21 highlights A lifetime of hearing solutions Innovating to build a market‐leading portfolio of products and services that provides a lifetime of hearing solutions for recipients. Strengthening our market leadership position with new products and services Nucleus® SmartNav System Custom Sound® Pro
Slide 9: FY21 highlights
FY21 highlights Empowered customers Improving the wellbeing of recipients and providing convenience and confidence to our professional customers. Providing the latest technology to our Improving outcomes through skills existing customers training Cochlear™ Baha® 6 Cochlear™ Nucleus® Kanso® 2 Cochlea
Slide 10: FY21 highlights
FY21 highlights Sustained value Maximising spending to grow the market and maintain our competitive position. Agile, efficient and environmentally responsible business processes to support our growth ambitions. Investing to grow Strong financial position • Record sales revenue, up 19% in CC • Underl
Slide 11: Resolution 1.1 Financial and other reports
Resolution 1.1 Financial and other reports To receive and consider the Company’s Financial report, the Directors’ report and the Auditor’s report in respect of the financial year ended 30 June 2021 and to consider and, if thought fit, to pass the following resolution: 1.1 “THAT the Company’s Financi
Slide 12: Resolution 1.1 Financial and other reports
Resolution 1.1 Financial and other reports Proxies and direct votes have been received in respect of this resolution as follows: No. of shares % For 44,851,817 96.1% Undirected 252,552 0.5% Against 1,594,763 3.4% 12
Slide 13: Resolution 2.1 Remuneration report
Resolution 2.1 Remuneration report To consider and, if thought fit, to pass the following non‐binding resolution: 2.1 “THAT the Company’s Remuneration report in respect of the financial year ended 30 June 2021 be adopted.” 13
Slide 14: Resolution 2.1 Remuneration report
Resolution 2.1 Remuneration report Proxies and direct votes have been received in respect of this resolution as follows: No. of shares % For 44,147,761 95.4% Undirected 235,920 0.5% Against 1,904,388 4.1% 14
Slide 15: Resolutions 3.1 – 3.3 Re-election of directors
Resolutions 3.1 – 3.3 Re‐election of directors Alison Deans Glen Boreham, AM Christine McLoughlin, AM 15
Slide 16: Resolution 3.1 Re-election of directors – Alison Deans
Resolution 3.1 Re‐election of directors – Alison Deans To consider and, if thought fit, to pass the following resolutions as ordinary resolutions: 3.1 “THAT Ms Alison Deans, being a director who is retiring in accordance with the Company’s Constitution and who, being eligible, offers herself for re‐
Slide 17: Resolution 3.1 Re-election of directors – Alison Deans
Resolution 3.1 Re‐election of directors – Alison Deans Proxies and direct votes have been received in respect of this resolution as follows: No. of shares % For 45,254,965 95.8% Undirected 235,127 0.5% Against 1,725,319 3.7% 17
Slide 18: Resolution 3.2 Re-election of directors – Glen Boreham, AM
Resolution 3.2 Re‐election of directors – Glen Boreham, AM To consider and, if thought fit, to pass the following resolutions as ordinary resolutions: 3.1 “THAT Mr Glen Boreham, AM, being a director who is retiring in accordance with the Company’s Constitution and who, being eligible, offers himself
Slide 19: Resolution 3.2 Re-election of directors – Glen Boreham, AM
Resolution 3.2 Re‐election of directors – Glen Boreham, AM Proxies and direct votes have been received in respect of this resolution as follows: No. of shares % For 45,266,182 96.1% Undirected 235,634 0.5% Against 1,620,135 3.4% 19
Slide 20: Resolution 3.3 Re-election of directors – Christine McLoughlin, AM
Resolution 3.3 Re‐election of directors – Christine McLoughlin, AM To consider and, if thought fit, to pass the following resolutions as ordinary resolutions: 3.1 “THAT Ms Christine McLoughlin, AM, being a director who is retiring in accordance with the Company’s Constitution (this being the first A
Slide 21: Resolution 3.3 Re-election of directors – Christine McLoughlin, AM
Resolution 3.3 Re‐election of directors – Christine McLoughlin, AM Proxies and direct votes have been received in respect of this resolution as follows: No. of shares % For 46,387,939 98.3% Undirected 235,367 0.5% Against 589,373 1.2% 21
Slide 22: Resolution 4.1 Approval of securities to be granted to the CEO & President
Resolution 4.1 Approval of securities to be granted to the CEO & President under the Cochlear Equity Incentive Plan To consider and, if thought fit, to pass the following resolution as an ordinary resolution: 5.1 “THAT approval be given for all purposes for the grant to Mr Dig Howitt, the Company’s
Slide 23: Resolution 4.1 Approval of securities to be granted to the CEO & President
Resolution 4.1 Approval of securities to be granted to the CEO & President under the Cochlear Equity Incentive Plan Proxies and direct votes have been received in respect of this resolution as follows: No. of shares % For 44,598,888 97.5% Undirected 235,588 0.5% Against 921,047 2.0% 23
Slide 24: Notes
Notes Hear now. And always Forward looking statements Cochlear advises that this document contains forward‐looking statements which may be subject to significant uncertainties outside of Cochlear’s control. No representation is made as to the accuracy or reliability of forward‐looking statements or
Slide 25: www.cochlear.com
www.cochlear.com © Cochlear Limited 2021